These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7904547)

  • 21. Effects of auranofin and other antirheumatic drugs on human myelopoiesis in vitro.
    Hamilton JA; Williams N
    J Rheumatol; 1987 Apr; 14(2):216-20. PubMed ID: 2885415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the effects of pharmacological agents on antigen-induced arthritis in BALB/c mice.
    Crossley MJ; Spowage M; Hunneyball IM
    Drugs Exp Clin Res; 1987; 13(5):273-7. PubMed ID: 2890505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalarials in rheumatic diseases.
    Tett S; Cutler D; Day R
    Baillieres Clin Rheumatol; 1990 Dec; 4(3):467-89. PubMed ID: 2093438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.
    Verbeeck RK
    Clin Pharmacokinet; 1990 Jul; 19(1):44-66. PubMed ID: 2199127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of hydroxychloroquine as an antirheumatic drug.
    Fox RI
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):82-91. PubMed ID: 8278823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug therapy for juvenile arthritis.
    Duffy CM; Laxer RM; Silverman ED
    Compr Ther; 1989 Oct; 15(10):48-59. PubMed ID: 2572375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
    Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
    Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial drug induced decrease in creatinine clearance.
    Landewé RB; Vergouwen MS; Goeei The SG; Van Rijthoven AW; Breedveld FC; Dijkmans BA
    J Rheumatol; 1995 Jan; 22(1):34-7. PubMed ID: 7699677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of hydroxychloroquine tablets in healthy volunteers.
    Tett SE; Cutler DJ; Day RO; Brown KF
    Br J Clin Pharmacol; 1989 Jun; 27(6):771-9. PubMed ID: 2757893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative evaluation of parenteral and oral preparations of gold and D-penicillamine in the treatment of rheumatoid nephropathy].
    Chichasova NV; Kanevskaia MZ; Slobodina GA; Varshavskiĭ VA; Krel' OV; Krel' AA
    Ter Arkh; 1991; 63(5):97-101. PubMed ID: 1679571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of rheumatoid arthritis: unknown long-term effects.
    Prescrire Int; 2001 Apr; 10(52):55-61. PubMed ID: 11718162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial.
    Brewer EJ; Giannini EH; Kuzmina N; Alekseev L
    N Engl J Med; 1986 May; 314(20):1269-76. PubMed ID: 3517643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.